A brief share flagging a study on GLP-1 medications and overdose as the opioid epidemic shifts, with few details given beyond the link.
Recap by typeshit. Video by Dr. Rick Pescatore, BellyMD on TikTok.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short clip with lifestyle pointers tagged around protein, strength training and exercise for people on the drug. No specifics are given.
Shea's team is joining a protein design competition aimed at building a new protein that switches on the same receptor Ozempic targets.
Loading…